P106: Binding properties of human TLR-9 receptor to cobitolimod – a candidate for treatment of active ulcerative colitis in late stage of clinical developmentECCO '17 Barcelona
2017
P107: Lactobacillus plantarum 06CC2 induces intestinal IL-10–producing dendritic cells to ameliorate acute experimental colitis in miceECCO '17 Barcelona
2017
P108: Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patientsECCO '17 Barcelona
2017
P109: Profiling of receptor for advanced glycation end products expression in cases of primary sclerosing cholangitis with ulcerative colitisECCO '17 Barcelona
2017
P110: Characterization of human intestinal macrophage subsets in health and inflammatory bowel diseaseECCO '17 Barcelona
2017
P111: The anti-inflammatory effect of a serine protease inhibitor in a chronic colitis transfer model is mediated by the suppression of Th1 cell differentiationECCO '17 Barcelona
2017
P112: Short-chain fatty acids administration is protective in colitis-associated colorectal cancer developmentECCO '17 Barcelona
2017
P113: Model based predictions of the PTG-100 pharmacodynamic responses in ulcerative colitis patientsECCO '17 Barcelona
2017
P115: Escherichia coli Nissle 1917 modulate gut microbiota composition in ulcerative colitis patientsECCO '17 Barcelona
2017
P116: Escherichia coli Nissle 1917 distinctively regulates apoptosis and cell cycling of Caco-2 cellsECCO '17 Barcelona
2017
P117: Functional implications of microRNAs in Crohn's disease revealed by integrating microRNA and messenger RNA expression profilingECCO '17 Barcelona
2017
P118: Balancing JAK/STAT-signaling with Tofacitinib in monocytes of healthy controls and IBD patientsECCO '17 Barcelona
2017
P119: Higher levels of infliximab may alleviate the need of azathioprine comedication in the treatment of patients with Crohn's disease: a SONIC post hoc analysisECCO '17 Barcelona
2017
P120: A single-nucleotide polymorphism in the vitamin D receptor gene is associated with a B3-penetrating phenotype in Crohn's diseaseECCO '17 Barcelona
2017
P121: Antimicrobial antibodies and inflammatory markers are present in the serum of patients with IBD years before diagnosis and can predict diseaseECCO '17 Barcelona
2017
P122: Magnetic resonance index of activity (MaRIA) and Clermont score are two MRI indices which are highly and equally effective in detecting mucosal healing in Crohn's diseaseECCO '17 Barcelona
2017
P123: MRI remission after therapeutic intervention is associated with more time spent in clinical corticosteroids-free remission and decreased risk of surgery in Crohn's diseaseECCO '17 Barcelona
2017